Marie Dominique Ah Kioon

Marie Dominique Ah Kioon

Auto-generated profile, based on publicly available information

Marie Dominique Ah Kioon

HSS Research Institute and David Z. Rosensweig Genomics Research Center, Hospital for Special Surgery, New York, USA

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 January 2018 in Science Translational Medicine
Verified
Journal Article
Closed access
PDF file
MKMarie Dominique Ah Kioon
Marie Dominique Ah Kioon
CTClaudio Tripodo
Claudio Tripodo
DFDavid Fernandez
David Fernandez
KKKyriakos Kirou
Kyriakos Kirou
RSRobert F. Spiera
Robert F. Spiera
FBFranck J. Barrat
Franck J. Barrat
The production of CXCL4 and IFN-α by plasmacytoid DCs in response to TLR8 signaling contributes to skin fibrosis and systemic sclerosis.

2 September 2022 in Journal of Experimental Medicine
Verified
Journal Article
Open access
PDF file
VCVidyanath Chaudhary
Vidyanath Chaudhary
MKMarie Dominique Ah Kioon
Marie Dominique Ah Kioon
Sung-Min HwangSung-Min Hwang
Sung-Min Hwang
BMBikash Mishra
Bikash Mishra
KLKimberly Lakin
Kimberly Lakin
FBFranck J. Barrat
Franck J. Barrat
Plasmacytoid dendritic cells (pDCs) chronically produce type I interferon (IFN-I) in autoimmune diseases, including systemic sclerosis (SSc) and systemic lupus erythematosus (SLE). We report that the IRE1α-XBP1 branch of the unfolded protein response (UPR) inhibits IFN-α production by TLR7- or TLR9-activated pDCs. In SSc patients, UPR gene expression was reduced in pDCs, which inversely correlated with IFN-I–stimulated gene expression. CXCL4, a chemokine highly secreted in SSc patients, downregulated IRE1α-XBP1–controlled genes and promoted IFN-α production by pDCs. Mechanistically, IRE1α-XBP1 activation rewired glycolysis to serine biosynthesis by inducing phosphoglycerate dehydrogenase (PHGDH) expression. This process reduced pyruvate access to the tricarboxylic acid (TCA) cycle and blunted mitochondrial ATP generation, which are essential for pDC IFN-I responses. Notably, PHGDH expression was reduced in pDCs from patients with SSc and SLE, and pharmacological blockade of TCA cycle reactions inhibited IFN-I responses in pDCs from these patients. Hence, modulating the IRE1α-XBP1–PHGDH axis may represent a hitherto unexplored strategy for alleviating chronic pDC activation in autoimmune disorders.

6 August 2025 in Nature
Verified
Journal Article
Closed access
PDF file
VGVincent R. Graziano
Vincent R. Graziano
JPJennifer Porat
Jennifer Porat
MKMarie Dominique Ah Kioon
Marie Dominique Ah Kioon
IMIvana Mejdrová
Ivana Mejdrová
AMAlyssa J. Matz
Alyssa J. Matz
VRVijay A. Rathinam
Vijay A. Rathinam

14 June 2022 in Nature Communications
Verified
Journal Article
Open access
PDF file
CYChao Yang
Chao Yang
MBMahesh Bachu
Mahesh Bachu
YDYong Du
Yong Du
CBCaroline Brauner
Caroline Brauner
RYRuoxi Yuan
Ruoxi Yuan
LILionel B. Ivashkiv
Lionel B. Ivashkiv
Regulation of endosomal Toll-like receptor (TLR) responses by the chemokine CXCL4 is implicated in inflammatory and fibrotic diseases, with CXCL4 proposed to potentiate TLR responses by binding to nucleic acid TLR ligands and facilitating their endosomal delivery. Here we report that in human monocytes/macrophages, CXCL4 initiates signaling cascades and downstream epigenomic reprogramming that change the profile of the TLR8 response by selectively amplifying inflammatory gene transcription and interleukin (IL)−1β production, while partially attenuating the interferon response. Mechanistically, costimulation by CXCL4 and TLR8 synergistically activates TBK1 and IKKε, repurposes these kinases towards an inflammatory response via coupling with IRF5, and activates the NLRP3 inflammasome. CXCL4 signaling, in a cooperative and synergistic manner with TLR8, induces chromatin remodeling and activates de novo enhancers associated with inflammatory genes. Our findings thus identify new regulatory mechanisms of TLR responses relevant for cytokine storm, and suggest targeting the TBK1-IKKε-IRF5 axis may be beneficial in inflammatory diseases.

31 May 2022 in Journal of Experimental Medicine
Verified
Journal Article
Open access
PDF file
YDYong Du
Yong Du
MKMarie Dominique Ah Kioon
Marie Dominique Ah Kioon
PLPaoline Laurent
Paoline Laurent
VCVidyanath Chaudhary
Vidyanath Chaudhary
MPMichael Pierides
Michael Pierides
FBFranck J. Barrat
Franck J. Barrat
Chemokines control the migratory patterns and positioning of immune cells to organize immune responses to pathogens. However, many chemokines have been associated with systemic autoimmune diseases that have chronic IFN signatures. We report that a series of chemokines, including CXCL4, CXCL10, CXCL12, and CCL5, can superinduce type I IFN (IFN-I) by TLR9-activated plasmacytoid DCs (pDCs), independently of their respective known chemokine receptors. Mechanistically, we show that chemokines such as CXCL4 mediate transcriptional and epigenetic changes in pDCs, mostly targeted to the IFN-I pathways. We describe that chemokines physically interact with DNA to form nanoparticles that promote clathrin-mediated cellular uptake and delivery of DNA in the early endosomes of pDCs. Using two separate mouse models of skin inflammation, we observed the presence of CXCL4 associated with DNA in vivo. These data reveal a noncanonical role for chemokines to serve as nucleic acid delivery vectors to modulate TLR signaling, with implications for the chronic presence of IFN-I by pDCs in autoimmune diseases.

13 December 2024 in Journal of Experimental Medicine
Verified
Journal Article
Open access
YDYong Du
Yong Du
BFBérénice Faz-Lopez
Bérénice Faz-Lopez
MKMarie Dominique Ah Kioon
Marie Dominique Ah Kioon
CCClaire Cenac
Claire Cenac
MPMichael Pierides
Michael Pierides
FBFranck J. Barrat
Franck J. Barrat
Systemic sclerosis (SSc) is an autoimmune disease that has a strong female predominance. Both the X-linked TLR7 and TLR8 can induce type I IFN (IFN-I) by plasmacytoid DCs (pDCs), which can promote fibrosis. We identified five subclusters of pDCs, including ISGhigh clusters that were over-represented in SSc patients. We observed that both TLR7 and TLR8 genes escape from X chromosome inactivation (XCI) at higher frequency in pDCs of SSc patients, which was associated with changes in TLR7 protein profile. Combined DNA/RNA FISH analysis revealed that the TLR7/8 locus is preferentially located outside of the inactive X (Xi) territory when TLR7 is expressed, suggesting that higher-order loop formation is linked to TLR7/8 expression from the Xi. Furthermore, the expression levels of XIST and the transcriptional repressor SPEN were reduced in SSc pDCs. Hence, our data revealed the heterogeneity of pDCs in SSc and suggested that altered XCI at the TLR7/8 locus may contribute to the chronic IFN-I activity of pDCs in female SSc patients.